Skin care represents the dominant application within the Cannabidiol (CBD) Cosmetics segmentation, accounting for roughly 45 % of total revenue. Products such as facial creams, serums, and moisturizers leverage CBD’s reported anti‑oxidant and anti‑inflammatory properties, driving adoption among consumers seeking clinically positioned skincare solutions. Hair care follows with an estimated 25 % share; shampoos, conditioners, and scalp treatments incorporate CBD to address sebaceous regulation and follicular health, a niche that has expanded through dermatological endorsements. Body care contributes about 20 % of the market, encompassing body lotions, balms, and post‑sun formulations where CBD’s soothing effect supports recovery from environmental stressors. Oral care holds the remaining 10 %, featuring toothpaste and mouthwash that exploit CBD’s antimicrobial activity. The proportional distribution reflects both product development cycles and regulatory acceptance, with skin‑focused offerings benefiting from the most extensive clinical validation, thereby anchoring overall market size. Consequently, investment in formulation science for skin‑care products is likely to sustain the majority of revenue growth over the next forecast horizon.